Guest
Signals accepts guest blog posts on topics relevant to stem cells and regenerative medicine, as well as submissions for its Right Turn Friday feature. The opinions, accuracy, completeness and validity of any statements made in guest posts are the responsibility of the author only and not the editor of Signals or CCRM, publisher of Signals. The copyright of this content belongs to the author and any liability with regards to infringement of intellectual property rights remains with the author. To reach the publisher, email info(at)CCRM.ca
Posts by: Guest
After agonizing delay, UK rejoins Horizon Europe funding scheme
Anis Fahandej-Sadi is a Business Development Associate at OmniaBio Inc., with more than three years’ business development experience across laboratory and GMP instrumentation, and now manufacturing services in the cell and gene therapy space. After receiving his Master’s in Chemistry from the University of Alberta in 2018, Anis taught English in Korea for one year. […]
Translational efficiency will be key for cell and gene therapies entering future markets
Josee Champagne is the co-founder and director of weCANtrial Consulting Group, Inc., a partner of the weCANtranslate Network; Associate Director of Clinical Development at Northern Therapeutics and UC-CISS Program Manager at the Ottawa Hospital Research Institute (OHRI) . She has supported investigator-led and industry sponsored clinical research for 20+years and has assisted in the translation […]
For advanced therapies, the sky’s the limit
Phil Vanek is responsible for technical due diligence and evaluation of potential investments, as well as guiding operational, R&D and strategic initiatives carried out at portfolio companies. An entrepreneurial and strategic international business leader, Phil joins Gamma Biosciences from GE Healthcare’s Cell and Gene Therapy business unit where he directed strategy and portfolio growth. Phil received his […]
Science communication: The skillset our field desperately needs
Ben McLeod has been fascinated by cellular biology since he was 13. He remembers learning that cells are just like miniature cities – with factories, data storage, waste disposal, transportation and communication systems. That fascination drives his work in cell and gene therapy (CGT) today. He has honed his skills in CGT manufacturing, technical strategy and […]
HeLa Ethics: Toward a more equitable future of regenerative medicine
Rebecca Ihilchik is Manager, Communications at CCRM supporting OmniaBio Inc. Drawing on a decade of experience in healthtech, non-profits, and higher education, she is most passionate about the storytelling aspect of professional communications. Rebecca holds a BA Hons in Creative Writing from York University, an MA in Religion from the University of Toronto, and a […]